November 9, 2015 / 2:53 PM / 4 years ago

BRIEF-Immunicum: EPO intends to grant patent to its cancer immune primer INTUVAX

Nov 9 (Reuters) - Immunicum AB :

* European Patent Office (EPO) intends to grant a patent relating to the company’s cancer immune primer, INTUVAX

* Patent application regarding the cancer immune primer INTUVAX will be granted in Europe Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below